This was further confirmed in additional assays, and by querying our human cohorts, in which decreased linc-GALNTL6-4 in obese subjects associated with the onset of hypertriglyceridemia and dysregulation of adipose APOC1 gene expression, enhanced response to fatty acids, and impaired adipose tissue activity. The gene discussed is APOC1; the disease is hypertriglyceridemia.